Back to the main directory
Press Release
- Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering by GlobeNewsWire
- Nokia Oyj: Omien osakkeiden takaisinosto 04.08.2023 by GlobeNewsWire
- Synaptics to Participate at Upcoming Investor Conferences Monday, August 7, 2023 and Tuesday, August 8, 2023 by GlobeNewsWire
- EQS-News: Pyrum Innovations AG: Aufsichtsratsmitglied erwirbt außerbörslich Aktien vom Vorstand by EQS Group AG
- Gillette Stadium to Feature Largest Outdoor End Zone Display in Professional Football from Daktronics by GlobeNewsWire
- Senvest Capital Inc. Reports Results for the Second Quarter Ended June 30, 2023 by GlobeNewsWire
- Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to September 10, 2023 by GlobeNewsWire
- Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares by GlobeNewsWire
- Savara Announces New Employment Inducement Grant by BusinessWire
- NANOBIOTIX annonce une assemblée générale extraordinaire qui se tiendra le 1er septembre 2023 by GlobeNewsWire
- Alta Equipment Group Inc. Announces Full Exercise of Option in Secondary Offering of Common Stock by GlobeNewsWire
- Grupo Aeroportuario del Pacifico Reports in July 2023 a Passenger Traffic Increase of 11.5% Compared to 2022 by GlobeNewsWire
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- Aceragen, Inc. to Delist from The Nasdaq Stock Market by GlobeNewsWire
- Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- Silvano Fashion Group Consolidated Interim Financial Report for Q2 and 6 months of 2023 (unaudited) by GlobeNewsWire
- Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023 by GlobeNewsWire
- Lightspeed annonce le résultat des votes lors de son assemblée annuelle et extraordinaire des actionnaires by GlobeNewsWire
- Equity Bancshares, Inc. Announces Promotion of Chris Navratil to Chief Financial Officer and Departure of Eric Newell by GlobeNewsWire
- Pineapple Energy to Release Second Quarter 2023 Results, Host Conference Call on August 11 by GlobeNewsWire
- Vivoryon Therapeutics N.V. Extraordinary General Meeting to Confirm New Executive Director Appointments to the Board, Being Held on September 15, 2023 by GlobeNewsWire
- FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder by GlobeNewsWire